BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14625824)

  • 1. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
    Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxis.
    Busebee B; Myhre L; Mara K; Aqel B; Taner T; Watt KD
    Clin Transplant; 2024 Feb; 38(2):e15263. PubMed ID: 38375953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Hepatitis B Virus Serology Profile-Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative-In Hepatitis B Virus/HIV Coinfected Individuals in Botswana.
    Phinius BB; Anderson M; Mokomane M; Gobe I; Choga WT; Ratsoma T; Phakedi B; Mpebe G; Ditshwanelo D; Musonda R; Makhema J; Moyo S; Gaseitsiwe S
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients.
    Yin S; Wu L; Zhang F; Huang X; Wu J; Wang X; Lin T
    Liver Int; 2023 Nov; 43(11):2415-2424. PubMed ID: 37592870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment.
    Axiaris G; Zampeli E; Michopoulos S; Bamias G
    World J Gastroenterol; 2021 Jul; 27(25):3762-3779. PubMed ID: 34321842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Hepatitis B Virus Markers among the Women with Breast Cancer.
    Fakheri Sueini V; Parsa Nahad M; Talaeizadeh A; Moradi M; Alborzi A; Pirmoradi R; Lak E; Makvandi M
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):547-553. PubMed ID: 38415541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept.
    Schwarz C; Morel A; Matignon M; Grimbert P; Rondeau E; Ouali N; François H; Mesnard L; Petit-Hoang C; Rafat C; Dahan K; Luque Y
    Kidney Int Rep; 2023 Aug; 8(8):1531-1541. PubMed ID: 37547512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients.
    Elghannam DM; Aly RM; Goda EF; Eltoraby EE; Farag RE
    Asian J Transfus Sci; 2009 Jan; 3(1):14-7. PubMed ID: 20041091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures.
    Beykaso G; Mulu A; Giday M; Berhe N; Selamu M; Mihret A; Teklehaymanot T
    Risk Manag Healthc Policy; 2021; 14():4843-4852. PubMed ID: 34880693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis D virus reactivation in liver-transplanted patients receiving hepatitis B immunoglobulin.
    Ganbold A; Bayarsaikhan S; Chimedtseren M; Noronrenchin O; Ochirkhuree B
    Clin Transplant Res; 2024 Mar; 38(1):46-51. PubMed ID: 38448049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult Hepatitis B Reactivation after Liver Transplant: The Role of a Novel Mutation in the Surface Antigen.
    Bedi HK; Chahal D; Lowe CF; Ritchie G; Hussaini T; Marquez V; Yoshida EM
    J Clin Transl Hepatol; 2021 Feb; 9(1):136-138. PubMed ID: 33604265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV reactivation in allogeneic stem cell transplant recipients: Risk factors, outcome, and role of hepatitis B virus mutations.
    Anastasiou OE; Almpani F; Herrmann A; Gerken G; Ditschkowski M; Ciesek S
    Hepatol Commun; 2017 Dec; 1(10):1014-1023. PubMed ID: 29404439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic Alert System Significantly Increases HBV Screening Rates Before Immunosuppressive Treatments.
    Köksal AŞ; Toka B; Sadeçolak M; Acar Ş; Eminler AT; Tozlu M; Karabay O
    Turk J Gastroenterol; 2023 May; 34(5):552-559. PubMed ID: 36939611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities.
    Bhatnagar A; Prakash S; Lymberopoulos P; Goff C; Shaikh A; Kim D; Ahmed A; Berg C; Naggie S; Kanwal F; Cholankeril G; Lee TH
    Am J Transplant; 2023 Aug; 23(8):1221-1226. PubMed ID: 37116583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of active vaccination against de novo hepatitis B among pediatric recipients of living donor liver transplantations with anti-HBc (+) grafts: a retrospective case-control study.
    Yong CC; Lin YH; Espinosa WZ; Chen IH; Wang SH; Chan YC; Chen CL; Lin CC
    Int J Surg; 2024 Jun; ():. PubMed ID: 38870007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related decline in anti-HBV antibodies in vaccinated kidney transplant recipients.
    Dadhania DM; Cravedi P; Blumberg E; Stryniak G; Montez-Rath ME; Maltzman JS
    Transpl Infect Dis; 2023 Aug; 25(4):e14090. PubMed ID: 37377328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus DNA and RNA persist in liver after serologic recovery in persons with hepatitis C virus.
    Grudda T; Thomas DL; Kirk GD; Mehta SH; Astemborski J; Lauer GM; Balagopal A; Thio CL
    J Infect Dis; 2024 May; ():. PubMed ID: 38779916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of kidney transplantation in patients with hepatitis B virus infection: A systematic review and meta-analysis.
    Thongprayoon C; Kaewput W; Sharma K; Wijarnpreecha K; Leeaphorn N; Ungprasert P; Sakhuja A; Cabeza Rivera FH; Cheungpasitporn W
    World J Hepatol; 2018 Feb; 10(2):337-346. PubMed ID: 29527269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of triple panel testing for hepatitis B and the burden of isolated anti-hepatitis B core antibodies within a community sample.
    Freeland C; Sreepathi V; Hass RW; Fenkel JM; Torgersen J; Rothstein K; Cohen C; Gish RG
    J Virus Erad; 2023 Dec; 9(4):100358. PubMed ID: 38174110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk factors and clinical outcomes in hepatitis B seropositive and seronegative renal transplant patients.
    Tsai YL; Chung MH; Lin NC; Chen CY; Lin YP; Tsai MT; Tsai HL; Chen YA; Ou SM; Chu CJ; Wu TH; Tsai CY
    Am J Nephrol; 2024 Mar; ():. PubMed ID: 38498992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.